Butylscopolamine Other names: Scopolamine butylbromide Hyoscine

Chemical formula: C₂₁H₃₀BrNO₄  Molecular mass: 360.473 g/mol  PubChem compound: 6852391

Active ingredient description

Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC Group Classification
A03BB01 Butylscopolamine A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03B BELLADONNA AND DERIVATIVES, PLAIN → A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
Discover more medicines within A03BB01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Document Type Information Source  
 BUSCOPAN Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 BUSCOPAN Coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 149-64-4
CAS Substance: 51-34-3
DrugBank Drug: DB09300
KEGG Drug: D01451
PubChem Compound: 6852391
RxNorm Ingredient: 1085787
SNOMED-CT Concept: 395739004
Scopolamine butylbromide (substance)
UNII Identifier: 2Z3E1OF81V
BUTYLSCOPOLAMINE

Medicines

Butylscopolamine is an active ingredient of these brands:

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

  • BUSCAPINA as BUTYLSCOPOLAMINE BROMIDE
  • ESPASMOTAB as BUTYLSCOPOLAMINE BROMIDE
  • (combination) BUSCAPINA DUO as BUTYLSCOPOLAMINE BROMIDE
  • (combination) DOLFEMIN DUAL as BUTYLSCOPOLAMINE BROMIDE
  • (combination) DOLOVAN as BUTYLSCOPOLAMINE BROMIDE
  • (combination) DUOPAS as BUTYLSCOPOLAMINE BROMIDE
  • (combination) ESPASMO Z-MOL as BUTYLSCOPOLAMINE BROMIDE
  • (combination) ESPASMOCOL as BUTYLSCOPOLAMINE BROMIDE
  • (combination) FEMMEXTRA as BUTYLSCOPOLAMINE BROMIDE
  • (combination) PARACOLIC as BUTYLSCOPOLAMINE BROMIDE
  • (combination) SINEPAS as BUTYLSCOPOLAMINE BROMIDE

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

  • BUSCOPAN as BUTYLSCOPOLAMINE BROMIDE
  • KWELLS as SCOPOLAMINE HYDROBROMIDE

Japan (JP)

  • BUSCOPAN as BUTYLSCOPOLAMINE BROMIDE
  • HYSCO as SCOPOLAMINE HYDROBROMIDE

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

United States (US)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈